Physician profile
Daniel C Leach
NPI 1366706954
$9,860.78
in general payments reported to CMS, 2019-2025
9 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,170 · 2020: $635 · 2021: $1,476 · 2022: $1,602 · 2023: $184 · 2024: $394 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873 · Gift: $76.28 · Entertainment: $28.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.00 |
| Gift | $76.28 |
| Entertainment | $28.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $5,661.83 | 2019-2021 | |
| Straumann USA LLC | $2,558.45 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $726.61 | 2021-2022 | |
| Zimvie INC. | $594.67 | 2022-2023 | |
| Nobel Biocare USA | $137.80 | 2019-2020 | |
| Stryker Corporation | $113.22 | 2019 | |
| Biohorizons Implant Systems INC. | $33.49 | 2025 | Biohorizons Dental Implants |
| Depuy Synthes Sales INC. | $22.21 | 2023 | Trumatch, Matrixorthognathic, Vivigen Mis Delivery System |
| Hu-Friedy Mfg. Co., LLC | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.